Numinus Wellness Inc.

CVE: NUMI


Canadian symbol: NUMI.V
US symbol: LKYSF

Currency in CAD

Valuation Measures

Market Cap (intraday) 5183.51M
Enterprise Value 3148.94M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)193.58
Price/Book (mrq)4.59
Enterprise Value/Revenue 3157.11
Enterprise Value/EBITDA 7-14.90

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-14.56%
S&P500 52-Week Change 343.61%
52 Week High 32.4500
52 Week Low 30.1850
50-Day Moving Average 30.9770
200-Day Moving Average 31.1053

Share Statistics

Avg Vol (3 month) 31.61M
Avg Vol (10 day) 3954.82k
Shares Outstanding 5199.37M
Implied Shares Outstanding 6N/A
Float 188.56M
% Held by Insiders 15.59%
% Held by Institutions 12.54%
Shares Short (Apr. 29, 2021) 4516.96k
Short Ratio (Apr. 29, 2021) 40.34
Short % of Float (Apr. 29, 2021) 4N/A
Short % of Shares Outstanding (Apr. 29, 2021) 40.26%
Shares Short (prior month Mar. 30, 2021) 4809.32k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 19, 2020
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug. 30, 2020
Most Recent Quarter (mrq)Feb. 27, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,096.48%

Management Effectiveness

Return on Assets (ttm)-32.62%
Return on Equity (ttm)-77.00%

Income Statement

Revenue (ttm)947.97k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-10.80%
Gross Profit (ttm)82.96k
EBITDA -10M
Net Income Avi to Common (ttm)-12.79M
Diluted EPS (ttm)-0.1230
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)28.58M
Total Cash Per Share (mrq)0.14
Total Debt (mrq)668.98k
Total Debt/Equity (mrq)2.05
Current Ratio (mrq)15.96
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)-11.04M
Levered Free Cash Flow (ttm)-6.73M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Psychedelics News and Psilocybin Investing

Real-time news from hundreds of sources. Never miss the news that matters the most.




Company News Date
NUMI.V
Numinus Wellness
3 days ago
NUMI.V
Numinus Wellness
3 days ago
NUMI.V
Numinus Wellness
4 days ago
NUMI.V
Numinus Wellness
4 days ago
NUMI.V
Numinus Wellness
1 week ago
NUMI.V
Numinus Wellness
2 weeks ago
NUMI.V
Numinus Wellness
2 weeks ago
NUMI.V
Numinus Wellness
1 month ago
NUMI.V
Numinus Wellness
1 month ago
NUMI.V
Numinus Wellness
1 month ago
NUMI.V
Numinus Wellness
1 month ago
NUMI.V
Numinus Wellness
2 months ago
NUMI.V
Numinus Wellness
2 months ago
NUMI.V
Numinus Wellness
2 months ago
NUMI.V
Numinus Wellness
2 months ago
NUMI.V
Numinus Wellness
2 months ago
NUMI.V
Numinus Wellness
2 months ago
NUMI.V
Numinus Wellness
2 months ago
NUMI.V
Numinus Wellness
2 months ago
NUMI.V
Numinus Wellness
3 months ago
NUMI.V
Numinus Wellness
3 months ago
NUMI.V
Numinus Wellness
4 months ago
NUMI.V
Numinus Wellness
4 months ago
NUMI.V
Numinus Wellness
5 months ago
NUMI.V
Numinus Wellness
5 months ago
NUMI.V
Numinus Wellness
5 months ago
NUMI.V
Numinus Wellness
5 months ago
NUMI.V
Numinus Wellness
5 months ago
NUMI.V
Numinus Wellness
5 months ago
NUMI.V
Numinus Wellness
5 months ago
NUMI.V
Numinus Wellness
6 months ago
NUMI.V
Numinus Wellness
6 months ago
NUMI.V
Numinus Wellness
6 months ago
NUMI.V
Numinus Wellness
6 months ago
NUMI.V
Numinus Wellness
6 months ago
NUMI.V
Numinus Wellness
6 months ago
NUMI.V
Numinus Wellness
6 months ago
NUMI.V
Numinus Wellness
6 months ago
NUMI.V
Numinus Wellness
7 months ago
NUMI.V
Numinus Wellness
7 months ago
NUMI.V
Numinus Wellness
8 months ago
NUMI.V
Numinus Wellness
8 months ago
NUMI.V
Numinus Wellness
8 months ago
NUMI.V
Numinus Wellness
9 months ago
NUMI.V
Numinus Wellness
10 months ago
NUMI.V
Numinus Wellness
10 months ago
NUMI.V
Numinus Wellness
11 months ago
NUMI.V
Numinus Wellness
11 months ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
5.59%% of Shares Held by All Insider
2.54%% of Shares Held by Institutions
2.69%% of Float Held by Institutions
5Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
tru Independence LLC111,000Dec. 30, 20200.06%118,770
FNY Investment Advisers, LLC20,000Mar. 30, 20210.01%21,400
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Numinus Wellness Inc.


Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application

Partnership Aimed at Delivering Psychedelic Capsule for Dosing Study in Human Clinical Trial  VANCOUVER, BC, May 11, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, and Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (... Read More...

Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab

Clinical trial will evaluate safety and psychoactive properties of natural Psilocybin product extracted and formulated at 7,000-square-foot laboratory in British Columbia, Canada VANCOUVER, BC, April 26, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-b... Read More...

Full-time classes resuming for secondary III, IV and V students in red zones: “A hasty and ill-advised decision given the spreading variants”

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Jan. 14, 2021 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic... Read More...

Swiss Re Corporate Solutions’ first North American collaboration with Canadian insurer, Economical Insurance, to provide access to its International Programme Administration (IPA) platform and network services

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Jan. 21, 2021 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic... Read More...

46th annual conference of the Institut des troubles d’apprentissage – Learning disabilities on the rise: dealing with the new teaching reality

VANCOUVER, BC, Feb. 18, 2021 - Trading resumes in:Company: Sona Nanotech Inc.CSE Symbol: SONAAll Issues: NonResumption (ET): 2:48 PMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the nationa... Read More...

Tergus Lauded by Frost & Sullivan for Its Full-spectrum CRO Services for Therapeutics in Dermatology

SANTA CLARA, Calif., March 8, 2021 -- Based on its recent analysis of the North American contract research organization (CRO) market in dermatology, Frost & Sullivan recognizes Tergus Pharma (Tergus) with the 2020 North America Customer Value Leadership Award. It has continually built on technical, professional, and structural capabil... Read More...

Regulatory approvals place Numinus lab at the forefront of global psychedelics research

Numinus Bioscience adds Ketamine and LSD to licence to produce, assemble and sell a wide variety of psychedelic compounds VANCOUVER, BC, March 4, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a global leader in supporting and expanding the safe, accessible and evidence-based use of psychedelic-assisted psychotherapies (PAP), has ... Read More...

LogiNext, a global logistics tech company, partners with AmRest, one of the largest franchise operators of KFC, Pizza Hut, Burger King and Starbucks on last mile deliveries

Proceeds add to recently executed warrants and options of $8.9 million /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Dec. 29, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing... Read More...

Voyager Digital Announces Year to Date Growth Metrics

VANCOUVER, BC, Dec. 29, 2020 - The following issues have been halted by IIROC:Company: Numinus Wellness Inc.TSX-Venture Symbol: NUMIAll Issues: YesReason: At the Request of the Company Pending NewsHalt Time (ET): 8:07 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company.... Read More...

Statement by the Prime Minister on the fourth anniversary of the fatal shooting at the Centre culturel islamique de Québec

OTTAWA, ON, Jan. 29, 2021 - The Prime Minister, Justin Trudeau, today issued the following statement to mark the fourth anniversary of the fatal shooting at the Centre culturel islamique de Québec:"Four years ago tonight, a terrorist attack at the Centre culturel islamique de Québec in Ste-Foy claimed the lives of six people and seriously... Read More...

Force One Capital is Retained to Provide Corporate Finance & Advisory Support to LocateMotion Inc.

TORONTO, Jan. 21, 2021 - Force One Capital Inc. ("Force One") is excited to announce it entered a strategic agreement with LocateMotion Inc. to provide capital markets and corporate finance advisory services in support of LocateMotion's upcoming financial offering.LocateMotion is the developer of Sensights.ai, an easy to use platform that... Read More...

Breeding tomorrow’s trees

The agreement will focus on developing safe, effective, all-natural products for the emerging psychedelic industry VANCOUVER, BC, Jan. 6, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedel... Read More...

Numinus Announces Grant of Stock Options

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Jan. 14, 2021 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic... Read More...

Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectometer

Acquisition of industry-leading instrument by Thermo Fisher Scientific will significantly advance psychedelic research and accelerate third-party standardized testing capabilities VANCOUVER, BC, Jan. 13, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing an... Read More...

Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products

The agreement will focus on developing safe, effective, all-natural products for the emerging psychedelic industry  VANCOUVER, BC, Jan. 6, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychede... Read More...

Numinus Announces Closing of $17 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Proceeds add to recently executed warrants and options of $8.9 million /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Dec. 29, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing... Read More...

Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming Français

The combination further enhances Numinus' leadership position in evidence-based psychedelic-assisted psychotherapy and health solutions VANCOUVER, BC, Dec. 15, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, acces... Read More...

Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming

The combination further enhances Numinus' leadership position in evidence-based psychedelic-assisted psychotherapy and health solutions VANCOUVER, BC, Dec. 15, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, acces... Read More...

Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme

 First-of-its-kind policy amendment will allow legal access to evidence-based treatments to those in need before formal drug approval  VANCOUVER, BC, Dec. 11, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, access... Read More...

Numinus Wellness Inc. Announces an Increase to the Previously Announced Bought Deal Public Offering

/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./VANCOUVER, BC, Dec. 7, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and suppo... Read More...

Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial

Monthly recurring revenue grows by more than 60% year over year. /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./OTTAWA, ON, Nov. 17, 2020 - Martello Technologies Group Inc., ("Martello") (TSXV: M... Read More...

Ontario Lottery and Gaming Corporation – MidDay lottery winning numbers – Nov. 18, 2020

Numinus Bioscience's developments include harvesting its first flush of Psilocybe mushrooms at its Health Canada licensed facility.VANCOUVER, BC, Oct. 22, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use ... Read More...

Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders

Open-label clinical trial will evaluate and refine best practices for the delivery of psilocybin-assisted psychotherapy for participants with tobacco, stimulant, alcohol, and/or opioid disorders VANCOUVER, BC, Nov. 18, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of solutions centred on the resear... Read More...

Media advisory – Minister Ng to speak virtually to young entrepreneurs during Small Business Week

OTTAWA, ON, Oct. 21, 2020 - The Honourable Mary Ng, Minister of Small Business, Export Promotion and International Trade, will join young entrepreneurs at the "Trailblazers: Mental Health and Entrepreneurship" online event hosted by Futurpreneur Canada, in partnership with BDC. The Minister will deliver opening remarks prior to panellists... Read More...

Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory

Numinus progresses on its ecosystem approach to the ultimate delivery of safe, evidence-based, accessible psychedelic-assisted psychotherapies VANCOUVER, BC, Sept. 24, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, ac... Read More...

Numinus Announces Listing of Warrants

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Sept. 18, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centred around developing and supporting the safe, evidence-based, accessible use of psychedelic... Read More...

Numinus Announces Filing of Final Short Form Prospectus for Offering of up to $4,000,000

/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/VANCOUVER, BC, Sept. 3, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted ther... Read More...

Numinus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms

Numinus becomes first publicly traded company in Canada approved to conduct research of this kind under a Health Canada licence VANCOUVER, BC, June 11, 2020 - Numinus Wellness Inc. (TSX-V:NUMI) ("Numinus") has received Health Canada approval to amend the Company's existing Licence under the Controlled Drug and Substances Act to allow Numi... Read More...

Numinus Announces 2020 Operational Plans to Scale

Company gives guidance on near-term business objectivesVANCOUVER , May 28, 2020 - Numinus Wellness Inc. ("Numinus"), recently listed on the TSX Venture Exchange (NUMI.V), is pleased to report its near-term goals to advance our mission to address the universal desire to heal.For 2020, the company plans to upgrade its lab and processing fac... Read More...

Dr. Gabor Maté, recognised physician and bestselling author, joins Numinus as Member of the Clinical Advisory Council

Maté will collaborate with the Numinus team in an advisory capacity and facilitate connections within the mental health communityVANCOUVER , May 26, 2020 - Numinus Wellness Inc. ("Numinus"; TSX-V: NUMI) is pleased to announce the appointment of Dr. Gabor Maté, MD, CM, as a Member of the Numinus Clinical Advisory Council. Through over 30 y... Read More...

Numinus Virtually Opens The Market

TORONTO , May 21, 2020 -https://www.youtube.com/watch?v=530qqxnrVgsAlongside team members, Payton Nyquvest , CEO and Founder of Numinus, joined Brady Fletcher , Managing Director & Head of TSX Venture Exchange to virtually open the market and celebrate the recent Numinus listing on TSX Venture Exchange. (NUMI.V) Numinus is a Vancouver... Read More...

Dr. Evan Wood, recognized leader in the field of substance use research and treatment, joins Numinus as Chief Medical Officer

Wood will lead research partnerships and the design of the Numinus patient-focused model VANCOUVER , May 21, 2020 - Numinus Wellness Inc. ("Numinus") is pleased to announce the appointment of Dr. Evan Wood , MD, PhD, ABIM, FASAM, FRCPC, ABAM Diplomat as Chief Medical Officer with Numinus, effective immediately. Dr. Wood, who over a 20-yea... Read More...
Coming Soon.
SymbolExchangePriceChangeAs of
NUMI.V
TSX Venture Exchange (former Canadian Ventures Exchange)
TSX Venture Exchange (former Canadian Ventures Exchange)0.90CAD+2.27%
LR23.F
Frankfurt Stock Exchange
Frankfurt Stock Exchange0.60EUR-5.59%
LKYSF.PK
US 'Other OTC' and Grey Market
US 'Other OTC' and Grey Market0.72USD--
LR23.BE
Berlin Stock Exchange
Berlin Stock Exchange0.61EUR+0.83%
LR23.MU
Munich Stock Exchange
Munich Stock Exchange0.62EUR0.00%
LR23.SG
Stuttgart Stock Exchange
Stuttgart Stock Exchange0.60EUR-1.08%
LKYSF.PQ
OTC MARKETS GROUP L1 AND L2
OTC MARKETS GROUP L1 AND L20.73USD--

Delayed data (1h)
NameAgePositionAppointed
Payton Nyquvest
Chairman of the Board, President, Chief Executive Officer
--Chairman of the Board, President, Chief Executive Officer2020
John Fong
Chief Financial Officer, Corporate Secretary
--Chief Financial Officer, Corporate Secretary2020
Michael Tan
Chief Operating Officer, Director
--Chief Operating Officer, Director2020
Kraig Docherty
Chief People Officer
--Chief People Officer--
Devon Christie
Medical Director and Member of Clinical Advisory Council
--Medical Director and Member of Clinical Advisory Council--
Kristina Grotzinger
Senior Research Scientist
--Senior Research Scientist--
Dorothea Hanisch
Head of Regulatory Affairs, QAP
--Head of Regulatory Affairs, QAP--
Bernd O. Keller
Senior Research Scientist
--Senior Research Scientist--
Judy Varga
Head of Laboratory Operations
--Head of Laboratory Operations--
Stacey Wallin
Chief Strategy Officer
--Chief Strategy Officer--
Evan Wood
Chief Medical Officer
--Chief Medical Officer--
Edwin Garner
Director
--Director2020
Larry Timlick
Director
63Director2019


Share this page